Maruho Report 2023

11/60

Maruho Report 2023Aug.10ProductProviding informationProviding informationJuneLaunched “Mitchga Treatment Support Service” as a LINE official social media account in support of treating itchiness due to atopic dermatitispp. 27–281.Maruho’s Meaning of Existence2.Value Creation ProspectsLicensingProviding information3.Strategy for Value Creation4.Foundation for Sustainable GrowthLicensingLicensingProviding informationSponsorship5.Financial/ Company InformationJulyObtained exclusive license for ALDH2 activatorpp. 23–24JulyLaunched “Don’t Tolerate Pincer Nails Project”p. 29JuneNational Health Insurance begins coverage for home self-injections of human anti-human IL-31 receptor A monoclonal antibody Mitchga SyringesJuneReleased new video on the information for acne treatment website “Project: Let’s cure acne together.”SeptemberSucceeded marketing approval for Tinea unguium antigen kit DermaQuick tinea unguiumSeptemberSigned licensing agreement with American pharmaceutical company for hyperhidrosis treatment in Asiapp. 23–24, p. 30SeptemberLaunched “Rosacea Navi,” a general information website on rosacea treatmentpp. 27–28SeptemberThrough sponsorship of the 61st Sendenkaigi Award Junior and Senior High School Division, we collected ideas on bringing smiles to friends who are concerned with their skin issuesJuneJulySep.